Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion type Assertion NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_head.
- NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion description "[Therefore, aberrant expression of miR-424-5p is critically involved in resistance to anoikis and EMT during the metastatic process of HCC, and its downregulation significantly contributes to liver cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_provenance.
- NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion evidence source_evidence_literature NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_provenance.
- NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion SIO_000772 25175916 NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_provenance.
- NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion wasDerivedFrom befree-2016 NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_provenance.
- NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_assertion wasGeneratedBy ECO_0000203 NP1215740.RAxloxJLdQ_DfIFk9-mSQHTll3D0AyXn3UI-PTxj7kl0k130_provenance.